Company description

BIFIDO Co., Ltd. was founded in 1999, in the spirit of challenge to pursue the best biotechnology and be the best in the field of the human microbiome.

Among various intestinal microbiome, Bifidobacterium is considered to be the most beneficial bacterium to maintain healthy intestinal microbial balance. BIFIDO has focused on research and development of Bifidobacterium spp. since 1999. Over 250 related scientific papers and 80 patents prove that BIFIDO is the top-tier company with the greatest experience and expertise in the microbiome industry.

Recently, BIFIDO started microbiome research on rheumatoid arthritis (RA), a chronic inflammatory disease. We analyzed the microbiota of RA patients and tried to find a way to treat even those who were less responsive to treatment. We have selected novel Bifidobacterium strains that can improve the symptoms of RA in animal models, and we expect new pharmabiotics from those strains. We are now expanding our pipelines for other immune-related diseases, including cancer.

Quick facts

Sales markets Asia; Australia; Eastern Europe; Middle East; North America; Western Europe
Primary business activity Contract Manufacturer; Manufacturer: Finished Food Products; Manufacturer: Ingredients / Additives; Raw Material Supplier
Affiliated categories: Food Supplements / Nutraceuticals |Functional Food |Nutrients More

Upcoming events

9 may 2023

Vitafoods Europe 2023

09 - 11 May 2023 Visit us at stand F260 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Bifido Co. Ltd.

Bifido Co. Ltd.

Contact information




View all contact information